Takip et
Nuri Faruk Aykan
Nuri Faruk Aykan
Diğer adlarFaruk Aykan, N. Faruk Aykan
İstinye Üniversitesi
isu.edu.tr üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
A Grothey, E Van Cutsem, A Sobrero, S Siena, A Falcone, M Ychou, ...
The Lancet 381 (9863), 303-312, 2013
30522013
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo …
ME Pavel, JD Hainsworth, E Baudin, M Peeters, D Hörsch, RE Winkler, ...
The Lancet 378 (9808), 2005-2012, 2011
11742011
Red meat and colorectal cancer
NF Aykan
Oncology reviews 9 (1), 2015
2612015
Colorectal cancer in young patients: characteristics and outcome
S Alici, NF Aykan, B Sakar, G Bulutlar, E Kaytan, E Topuz
The Tohoku journal of experimental medicine 199 (2), 85-93, 2003
1302003
Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease
F Tas, F Aykan, S Alici, E Kaytan, A Aydiner, E Topuz
American journal of clinical oncology 24 (6), 547-550, 2001
1242001
Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
DH Simsek, S Kuyumcu, C Turkmen, Y Sanlı, F Aykan, S Unal, I Adalet
Journal of Nuclear Medicine 55 (11), 1811-1817, 2014
1032014
Timing of death from tumor recurrence after curative gastrectomy for gastric cancer
B Sakar, H Karagol, M Gumus, M Basaran, E Kaytan, A Argon, Z Ustuner, ...
American journal of clinical oncology 27 (2), 205-209, 2004
982004
Objective response rate assessment in oncology: Current situation and future expectations
NF Aykan, T Özatlı
World Journal of Clinical Oncology 11 (2), 53, 2020
632020
A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric …
FD Içli F, Celik I, Aykan F, Uner A, Demirkazik A, Ozet A, Ozgüroğlu M, Taş ...
Cancer 83 (12), 2475-2480, 1998
54*1998
Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients
T Salepci, H Yazici, F Dane, E Topuz, N Dalay, H Onat, F Aykan, M Seker, ...
J BUON 14 (3), 495-9, 2009
522009
Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer
E Topuz, D Derin, G Can, E Kürklü, S Çınar, F Aykan, A Çevikbaş, R Dişçi, ...
Investigational New Drugs 26, 567-572, 2008
472008
Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial)
N Aykan, Ş YALÇIN, N Turhal, M Ozdogan, G Demir, M Özkan, A Yaren, ...
Turkish Journal of Gastroenterology 26 (2), 2015
462015
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis
B Sakar, Z Ustuner, H Karagol, G Aksu, H Camlica, NF Aykan
American journal of clinical oncology 27 (5), 489-493, 2004
362004
Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study
E Topuz, M Basaran, P Saip, A Aydiner, A Argon, B Sakar, F Tas, K Uygun, ...
American journal of clinical oncology 25 (6), 619-624, 2002
312002
Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer.
SMT Thirion P, Piedbois P, Buyse M, O'Dwyer PJ, Cunningham D, Man A, Greco ...
Br J Cancer 84 (5), 611-620, 2001
29*2001
Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma
M Karabulut, M Gunaldi, H Alis, CU Afsar, S Karabulut, M Serilmez, ...
Clinical and Translational Oncology 18, 160-171, 2016
282016
Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy
N Faruk Aykan, I Yildiz, F Sen, L Kilic, S Keskin, R Ciftci, S Karabulut, ...
Medical Oncology 30, 1-6, 2013
262013
The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival
F Tas, NF Aykan, A Aydiner, K Uygun, M Basaran, H Camlica, E Topuz
American journal of clinical oncology 23 (1), 53-57, 2000
222000
Bevacuzimab may be less effective in obese metastatic colorectal cancer patients
M Artaç, L Korkmaz, HŞ Coşkun, F Dane, B Karabulut, M Karaağaç, ...
Journal of gastrointestinal cancer 50, 214-220, 2019
212019
Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer
F Tas, NF Aykan, A Aydiner, V Yasasever, E Topuz
American journal of clinical oncology 24 (2), 148-149, 2001
212001
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20